RITONAVIR 100 MG

RITONAVIR 100 MG was reported 14912 times

RITONAVIR 100 MG is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA 104 0.8062
1 ULTRASOUND ANTENATAL SCREEN 56 0.5833
2 GLUCOCORTICOIDS INCREASED 11 0.5500
3 BLOOD HIV RNA 16 0.3077
4 CSF HIV ESCAPE SYNDROME 39 0.2826
5 AIDS ENCEPHALOPATHY 15 0.2586
6 FLOPPY EYELID SYNDROME 8 0.2286
7 HIV ASSOCIATED NEPHROPATHY 9 0.1765
8 ERYTHEMA ELEVATUM DIUTINUM 8 0.1739
9 ERGOT POISONING 21 0.1680
10 PERITONEAL CYST 9 0.1667
11 SCROTAL CYST 13 0.1529
12 MITOCHONDRIAL TOXICITY 118 0.1437
13 CD4 LYMPHOCYTES ABNORMAL 29 0.1381
14 AIDS DEMENTIA COMPLEX 8 0.1311
15 VIROLOGIC FAILURE 685 0.1273
16 LIPODYSTROPHY ACQUIRED 263 0.1238
17 ALPHA 1 FOETOPROTEIN ABNORMAL 12 0.1200
18 PULMONARY HAEMORRHAGE NEONATAL 11 0.1196
19 RETINOBLASTOMA 13 0.1193
20 HIV-ASSOCIATED NEUROCOGNITIVE DISORDER 13 0.1171
21 ECTOPIC KIDNEY 11 0.1158
22 CSF VIRUS IDENTIFIED 8 0.1143
23 CUSHING'S SYNDROME 76 0.1094
24 TRISOMY 18 41 0.1076
25 IMMUNE RECONSTITUTION SYNDROME 138 0.1069
26 VENTRICULAR HYPOPLASIA 25 0.1000
27 CHORDEE 14 0.0993
28 ADRENAL SUPPRESSION 82 0.0973
29 BLOOD ANTIDIURETIC HORMONE INCREASED 9 0.0968
30 HYPERCORTICOIDISM 10 0.0943
31 TERATOGENICITY 28 0.0927
32 CD4 LYMPHOCYTES DECREASED 186 0.0868
33 GENITALIA EXTERNAL AMBIGUOUS 15 0.0867
34 CONGENITAL NAEVUS 11 0.0775
35 PSYCHIATRIC DECOMPENSATION 151 0.0772
36 BLOOD HIV RNA INCREASED 139 0.0766
37 HIV VIRAEMIA 16 0.0762
38 HYDROPS FOETALIS 41 0.0669
39 VIRAL MUTATION IDENTIFIED 232 0.0629
40 LARYNGOMALACIA 21 0.0627
41 NEPHROANGIOSCLEROSIS 10 0.0621
42 NEONATAL RESPIRATORY ARREST 9 0.0616
43 RENAL TUBULAR DYSFUNCTION 34 0.0602
44 RENAL DYSPLASIA 23 0.0594
45 ULTRASOUND ANTENATAL SCREEN ABNORMAL 13 0.0591
46 FOETAL CHROMOSOME ABNORMALITY 10 0.0588
47 KAPOSI'S SARCOMA 29 0.0578
48 TRISOMY 21 70 0.0556
49 HETEROTAXIA 9 0.0539
50 ATRIOVENTRICULAR SEPTAL DEFECT 25 0.0532
51 OESOPHAGEAL ATRESIA 32 0.0512
52 BLOOD CORTISOL DECREASED 32 0.0500
53 SECONDARY ADRENOCORTICAL INSUFFICIENCY 75 0.0496
54 PERIVENTRICULAR LEUKOMALACIA 14 0.0495
55 PSYCHOMOTOR SKILLS IMPAIRED 129 0.0492
56 FACIAL WASTING 13 0.0483
57 NEONATAL SEIZURE 12 0.0482
58 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME ASSOCIATED TUBERCULOSIS 15 0.0448
59 NEUTROPENIA NEONATAL 10 0.0446
60 POST TRANSPLANT DISTAL LIMB SYNDROME 9 0.0443
61 SYPHILIS 32 0.0440
62 LIPOATROPHY 40 0.0420
63 CENTRAL OBESITY 31 0.0419
64 PATIENT ISOLATION 9 0.0419
65 CONGENITAL HYDROCEPHALUS 21 0.0414
66 MITOCHONDRIAL MYOPATHY 9 0.0413
67 TOTAL LUNG CAPACITY INCREASED 11 0.0404
68 LIPOHYPERTROPHY 25 0.0402
69 DEPRESSION SUICIDAL 138 0.0398
70 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 197 0.0395
71 ANAEMIA NEONATAL 19 0.0394
72 CHOLESTASIS OF PREGNANCY 18 0.0391
73 FANCONI SYNDROME ACQUIRED 68 0.0387
74 ACQUIRED IMMUNODEFICIENCY SYNDROME 20 0.0385
75 NEURAL TUBE DEFECT 28 0.0385
76 CONGENITAL HEART VALVE DISORDER 9 0.0378
77 ANION GAP ABNORMAL 10 0.0373
78 DEPRESSIVE SYMPTOM 131 0.0371
79 FIBROUS HISTIOCYTOMA 13 0.0370
80 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 121 0.0366
81 URINARY TRACT INFLAMMATION 13 0.0361
82 GENOTYPE DRUG RESISTANCE TEST POSITIVE 37 0.0360
83 SINGLE UMBILICAL ARTERY 13 0.0352
84 BLOOD BILIRUBIN UNCONJUGATED INCREASED 25 0.0344
85 HYPOTHALAMIC PITUITARY ADRENAL AXIS SUPPRESSION 12 0.0334
86 FANCONI SYNDROME 47 0.0332
87 VIRAL LOAD INCREASED 129 0.0332
88 CLEFT LIP AND PALATE 37 0.0331
89 TEARFULNESS 142 0.0330
90 HYPERADRENOCORTICISM 9 0.0327
91 EXTRAOCULAR MUSCLE PARESIS 15 0.0327
92 HUMAN IMMUNODEFICIENCY VIRUS TRANSMISSION 9 0.0324
93 PORTAL HYPERTENSIVE GASTROPATHY 18 0.0319
94 CONDUCTIVE DEAFNESS 10 0.0312
95 ANTICOAGULATION DRUG LEVEL INCREASED 10 0.0312
96 LEISHMANIASIS 9 0.0310
97 CENTRAL PAIN SYNDROME 8 0.0302
98 SPINA BIFIDA 61 0.0293
99 HEPATOBILIARY DISEASE 18 0.0288
100 BLOOD CORTICOTROPHIN DECREASED 14 0.0287
101 RETINAL TOXICITY 29 0.0282
102 NODULAR REGENERATIVE HYPERPLASIA 18 0.0280
103 PORTAL HYPERTENSION 86 0.0279
104 PATHOGEN RESISTANCE 254 0.0278
105 POLYHYDRAMNIOS 27 0.0264
106 CONGENITAL FOOT MALFORMATION 12 0.0264
107 PSYCHOMOTOR RETARDATION 74 0.0263
108 OPHTHALMOPLEGIA 41 0.0260
109 GLYCOSURIA 35 0.0259
110 MACROCEPHALY 10 0.0258
111 RENAL APLASIA 18 0.0256
112 CONGENITAL DIAPHRAGMATIC HERNIA 10 0.0256
113 CHRONIC HEPATITIS C 10 0.0253
114 VIRAEMIA 35 0.0253
115 SINGLE FUNCTIONAL KIDNEY 16 0.0242
116 CENTRAL HYPOTHYROIDISM 8 0.0242
117 LOW BIRTH WEIGHT BABY 192 0.0241
118 POLYDACTYLY 28 0.0241
119 CSF TEST ABNORMAL 12 0.0239
120 CALCULUS URINARY 36 0.0234
121 ANAL CANCER 22 0.0227
122 DIAPHRAGMATIC HERNIA 14 0.0226
123 STILLBIRTH 107 0.0221
124 DRUG RESISTANCE 556 0.0216
125 RENAL TUBULAR DISORDER 60 0.0213
126 ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME 11 0.0210
127 HIV INFECTION 63 0.0209
128 SKIN STRIAE 31 0.0208
129 HEPATITIS B DNA INCREASED 14 0.0208
130 HYPERBILIRUBINAEMIA NEONATAL 12 0.0206
131 PLEOCYTOSIS 12 0.0206
132 INTRAVENTRICULAR HAEMORRHAGE NEONATAL 10 0.0206
133 SUDDEN INFANT DEATH SYNDROME 10 0.0203
134 PYELOCALIECTASIS 19 0.0198
135 GENE MUTATION 39 0.0197
136 CUSHINGOID 63 0.0196
137 MONONEUROPATHY MULTIPLEX 9 0.0195
138 ANENCEPHALY 11 0.0195
139 CYSTITIS NONINFECTIVE 26 0.0194
140 HODGKIN'S DISEASE 14 0.0193
141 CEREBRAL TOXOPLASMOSIS 18 0.0193
142 FOETAL EXPOSURE DURING DELIVERY 13 0.0192
143 UMBILICAL CORD ABNORMALITY 10 0.0190
144 PREMATURE RUPTURE OF MEMBRANES 45 0.0186
145 EXOMPHALOS 10 0.0186
146 TOXOPLASMOSIS 20 0.0185
147 PREMATURE DELIVERY 294 0.0184
148 PNEUMOCOCCAL SEPSIS 12 0.0183
149 MYCOBACTERIUM AVIUM COMPLEX INFECTION 49 0.0182
150 CEREBRAL VENTRICLE DILATATION 21 0.0182
151 HYPERSPLENISM 9 0.0182
152 CONGENITAL MUSCULOSKELETAL ANOMALY 8 0.0181
153 LIVE BIRTH 150 0.0179
154 HYDROCELE 19 0.0178
155 SKULL MALFORMATION 11 0.0171
156 RENAL COLIC 38 0.0168
157 CONGENITAL HYDRONEPHROSIS 12 0.0168
158 PULMONARY HYPOPLASIA 13 0.0165
159 FOETAL EXPOSURE DURING PREGNANCY 1309 0.0161
160 HYPERBILIRUBINAEMIA 166 0.0160
161 ENCEPHALOMALACIA 9 0.0160
162 PANCREATITIS RELAPSING 13 0.0159
163 CYTOMEGALOVIRUS CHORIORETINITIS 31 0.0159
164 WHITE MATTER LESION 20 0.0158
165 VANISHING BILE DUCT SYNDROME 17 0.0152
166 CRYSTAL NEPHROPATHY 9 0.0152
167 PREMATURE BABY 456 0.0151
168 MYCOBACTERIAL INFECTION 26 0.0151
169 MENINGOMYELOCELE 9 0.0150
170 EROSIVE DUODENITIS 12 0.0150
171 CONGENITAL CENTRAL NERVOUS SYSTEM ANOMALY 16 0.0148
172 DYSLIPIDAEMIA 74 0.0146
173 COARCTATION OF THE AORTA 14 0.0145
174 CYTOGENETIC ABNORMALITY 16 0.0142
175 JARISCH-HERXHEIMER REACTION 10 0.0140
176 CHYLOTHORAX 10 0.0139
177 PREMATURE SEPARATION OF PLACENTA 21 0.0136
178 MULTIPLE-DRUG RESISTANCE 42 0.0135
179 OESOPHAGEAL CANDIDIASIS 53 0.0133
180 SMALL FOR DATES BABY 66 0.0133
181 PNEUMOCYSTIS JIROVECI PNEUMONIA 29 0.0130
182 DRUG INTERACTION 2050 0.0129
183 CHRONIC ALLOGRAFT NEPHROPATHY 10 0.0128
184 DELAYED GRAFT FUNCTION 9 0.0127
185 AMNIOTIC CAVITY INFECTION 9 0.0124
186 BONE DEMINERALISATION 13 0.0123
187 EYELID PTOSIS 124 0.0122
188 FOETAL DEATH 63 0.0121
189 ABORTION INDUCED 113 0.0120
190 HEART TRANSPLANT REJECTION 12 0.0116
191 ENCEPHALITIS VIRAL 14 0.0115
192 PLACENTA PRAEVIA 9 0.0115
193 RENAL TUBULAR ACIDOSIS 25 0.0114
194 LIMB MALFORMATION 9 0.0114
195 LIPIDS INCREASED 23 0.0114
196 AORTIC VALVE SCLEROSIS 8 0.0109
197 TWIN PREGNANCY 9 0.0107
198 NEPHROPATHY TOXIC 119 0.0106
199 INTRA-UTERINE DEATH 17 0.0106
200 INTUSSUSCEPTION 10 0.0105
201 EXPOSURE DURING PREGNANCY 650 0.0104
202 CAESAREAN SECTION 121 0.0104
203 ABORTION SPONTANEOUS 416 0.0104
204 NEPHRITIS INTERSTITIAL 13 0.0103
205 PREMATURE LABOUR 58 0.0102
206 HEART DISEASE CONGENITAL 36 0.0102
207 NEUROPSYCHIATRIC SYMPTOMS 9 0.0100
208 OROPHARYNGEAL CANDIDIASIS 9 0.0099
209 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 87 0.0098
210 FAT TISSUE INCREASED 14 0.0096
211 DRUG LEVEL INCREASED 155 0.0094
212 MICROCEPHALY 12 0.0094
213 ELECTRIC SHOCK 8 0.0093
214 ADRENAL INSUFFICIENCY 113 0.0093
215 CONDUCTION DISORDER 17 0.0093
216 PRE-ECLAMPSIA 44 0.0092
217 ACQUIRED GENE MUTATION 12 0.0092
218 HYPOSPADIAS 19 0.0091
219 ABDOMINAL SEPSIS 8 0.0091
220 LARGE FOR DATES BABY 8 0.0091
221 DRUG LEVEL FLUCTUATING 8 0.0090
222 LABELLED DRUG-DRUG INTERACTION ISSUE 13 0.0090
223 HYPERLACTACIDAEMIA 24 0.0089
224 HYPERTRIGLYCERIDAEMIA 52 0.0089
225 PARANOIA 152 0.0088
226 ECTOPIC PREGNANCY 27 0.0088
227 HYPOPERFUSION 9 0.0086
228 CACHEXIA 42 0.0082
229 BLOOD LACTIC ACID INCREASED 43 0.0082
230 GENERALISED ANXIETY DISORDER 12 0.0082
231 PORTAL VEIN THROMBOSIS 26 0.0080
232 MENINGITIS CRYPTOCOCCAL 14 0.0080
233 HEPATITIS CHOLESTATIC 48 0.0080
234 HYPOGONADISM 8 0.0079
235 FOETAL GROWTH RESTRICTION 48 0.0079
236 MATERNAL EXPOSURE DURING PREGNANCY 703 0.0079
237 INFECTION REACTIVATION 9 0.0079
238 BLOOD BILIRUBIN ABNORMAL 10 0.0078
239 CEREBELLAR SYNDROME 17 0.0078
240 DRUG CLEARANCE DECREASED 10 0.0077
241 MEGACOLON 12 0.0076
242 BLOOD AMYLASE INCREASED 13 0.0076
243 NEPHROCALCINOSIS 9 0.0076
244 HEPATITIS C 90 0.0074
245 POSTPARTUM HAEMORRHAGE 10 0.0074
246 BLOOD BILIRUBIN INCREASED 198 0.0073
247 HEPATITIS B 44 0.0073
248 MENINGITIS VIRAL 10 0.0073
249 DEATH NEONATAL 10 0.0072
250 NORMAL NEWBORN 39 0.0072
251 LIP DISCOLOURATION 9 0.0071
252 OSTEOMALACIA 11 0.0071
253 HEPATITIS B REACTIVATION 22 0.0069
254 OCULAR ICTERUS 30 0.0069
255 ALLODYNIA 8 0.0068
256 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 56 0.0068
257 PNEUMONIA PNEUMOCOCCAL 10 0.0067
258 VOLVULUS 16 0.0067
259 IMMUNOSUPPRESSANT DRUG LEVEL DECREASED 8 0.0067
260 MATERNAL DRUGS AFFECTING FOETUS 51 0.0066
261 VARICES OESOPHAGEAL 20 0.0066
262 AGORAPHOBIA 9 0.0066
263 PSYCHOTIC DISORDER 194 0.0066
264 HEPATITIS TOXIC 17 0.0065
265 OPPORTUNISTIC INFECTION 12 0.0065
266 VENTRICULAR SEPTAL DEFECT 37 0.0065
267 OESOPHAGEAL VARICES HAEMORRHAGE 14 0.0064
268 RENAL TUBULAR NECROSIS 63 0.0064
269 GLUCOSE URINE PRESENT 8 0.0063
270 JAUNDICE 168 0.0062
271 NEONATAL RESPIRATORY DISTRESS SYNDROME 22 0.0062
272 CONGENITAL ANOMALY 48 0.0062
273 COMPLICATIONS OF TRANSPLANTED KIDNEY 14 0.0062
274 PREGNANCY ON CONTRACEPTIVE 9 0.0062
275 ANAEMIA MACROCYTIC 13 0.0061
276 HIRSUTISM 8 0.0060
277 VENTRICULAR HYPERTROPHY 15 0.0060
278 HYPOPHOSPHATAEMIA 44 0.0059
279 HEPATOSPLENOMEGALY 15 0.0058
280 HYPOMANIA 21 0.0057
281 INHIBITORY DRUG INTERACTION 9 0.0057
282 FOETAL DISTRESS SYNDROME 12 0.0057
283 ACUTE LYMPHOCYTIC LEUKAEMIA 16 0.0056
284 ATRIOVENTRICULAR BLOCK FIRST DEGREE 24 0.0055
285 DRUG LEVEL ABOVE THERAPEUTIC 25 0.0055
286 CARDIAC MURMUR 47 0.0054
287 QUADRIPARESIS 9 0.0054
288 BENIGN PROSTATIC HYPERPLASIA 28 0.0054
289 HEPATIC CYTOLYSIS 69 0.0054
290 TREATMENT NONCOMPLIANCE 296 0.0054
291 HYPERTRICHOSIS 10 0.0054
292 PULMONARY TUBERCULOSIS 23 0.0054
293 ATRIAL SEPTAL DEFECT 44 0.0052
294 CEREBRAL ISCHAEMIA 27 0.0052
295 MYOGLOBIN BLOOD INCREASED 8 0.0052
296 OSTEOPOROSIS 212 0.0051
297 HEPATIC ENCEPHALOPATHY 48 0.0051
298 POTENTIATING DRUG INTERACTION 17 0.0051
299 PATENT DUCTUS ARTERIOSUS 20 0.0050
300 DRUG LEVEL DECREASED 51 0.0050
301 LONG QT SYNDROME 12 0.0050
302 MONOPARESIS 9 0.0050
303 HEPATOTOXICITY 109 0.0049
304 TALIPES 15 0.0048
305 DRUG EXPOSURE DURING PREGNANCY 162 0.0048
306 BLOOD BICARBONATE DECREASED 9 0.0047
307 MILIARIA 8 0.0046
308 GESTATIONAL DIABETES 22 0.0046
309 KIDNEY FIBROSIS 8 0.0046
310 NASAL SEPTUM DEVIATION 9 0.0046
311 TORSADE DE POINTES 36 0.0046
312 HYDROCEPHALUS 25 0.0046
313 HYPERAEMIA 9 0.0046
314 DYSAESTHESIA 14 0.0046
315 OSTEONECROSIS 150 0.0046
316 PREGNANCY 91 0.0045
317 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 35 0.0045
318 HEPATOMEGALY 44 0.0045
319 ACUTE HEPATIC FAILURE 61 0.0045
320 SPLENOMEGALY 52 0.0044
321 OSTEOPENIA 67 0.0044
322 OSTEOLYSIS 9 0.0044
323 GLOMERULAR FILTRATION RATE DECREASED 54 0.0044
324 ALANINE AMINOTRANSFERASE INCREASED 268 0.0044
325 BLOOD TRIGLYCERIDES INCREASED 77 0.0044
326 ENCEPHALITIS 30 0.0043
327 DIPLOPIA 112 0.0043
328 MYOPATHY 37 0.0043
329 PNEUMOCYSTIS JIROVECII PNEUMONIA 43 0.0043
330 BILIRUBIN CONJUGATED INCREASED 10 0.0043
331 SKIN HYPERTROPHY 12 0.0043
332 PROTEINURIA 81 0.0043
333 CLOSTRIDIUM DIFFICILE COLITIS 45 0.0042
334 ASPARTATE AMINOTRANSFERASE INCREASED 223 0.0042
335 ORAL CANDIDIASIS 55 0.0042
336 HYPERCHOLESTEROLAEMIA 40 0.0041
337 STRABISMUS 12 0.0041
338 HEPATIC FIBROSIS 14 0.0041
339 CONGESTIVE CARDIOMYOPATHY 17 0.0041
340 CLUMSINESS 11 0.0040
341 AUTOIMMUNE HEPATITIS 28 0.0040
342 RETINOPATHY 15 0.0040
343 AORTIC STENOSIS 14 0.0040
344 NEPHROLITHIASIS 184 0.0040
345 HYPERLIPIDAEMIA 47 0.0039
346 TREATMENT FAILURE 323 0.0039
347 LACTIC ACIDOSIS 125 0.0039
348 NEUROLOGICAL SYMPTOM 22 0.0038
349 BLOOD PHOSPHORUS DECREASED 14 0.0038
350 ESCHERICHIA BACTERAEMIA 9 0.0038
351 DISTURBANCE IN SOCIAL BEHAVIOUR 9 0.0038
352 DERMATITIS EXFOLIATIVE 19 0.0038
353 ODYNOPHAGIA 22 0.0037
354 HEPATOCELLULAR CARCINOMA 28 0.0037
355 JAUNDICE CHOLESTATIC 13 0.0037
356 METABOLIC ENCEPHALOPATHY 11 0.0037
357 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 14 0.0037
358 CYTOLYTIC HEPATITIS 12 0.0036
359 HYPERPARATHYROIDISM SECONDARY 9 0.0036
360 RENAL FAILURE ACUTE 151 0.0036
361 TRANSAMINASES INCREASED 79 0.0035
362 ANHEDONIA 93 0.0035
363 GASTROINTESTINAL TOXICITY 17 0.0035
364 DISSEMINATED TUBERCULOSIS 9 0.0035
365 CREATININE RENAL CLEARANCE DECREASED 14 0.0035
366 LOW DENSITY LIPOPROTEIN INCREASED 27 0.0035
367 HAEMATOTOXICITY 33 0.0035
368 HEPATIC CIRRHOSIS 65 0.0035
369 HYPERSENSITIVITY VASCULITIS 9 0.0034
370 LUNG OPACITY 9 0.0034
371 VITAMIN D DEFICIENCY 33 0.0034
372 MACULOPATHY 12 0.0034
373 DRUG TOXICITY 46 0.0034
374 ASCITES 96 0.0033
375 HEPATITIS ACUTE 21 0.0032
376 LUNG CONSOLIDATION 9 0.0032
377 NYSTAGMUS 17 0.0032
378 RASH MACULO-PAPULAR 71 0.0032
379 TUMOUR LYSIS SYNDROME 28 0.0032
380 LIVER INJURY 78 0.0032
381 HEPATIC FAILURE 95 0.0031
382 EUGLYCAEMIC DIABETIC KETOACIDOSIS 13 0.0031
383 RENAL IMPAIRMENT 262 0.0031
384 ACUTE KIDNEY INJURY 477 0.0031
385 NEPHROPATHY 29 0.0031
386 ESCHERICHIA SEPSIS 9 0.0031
387 ABORTION 9 0.0031
388 NEUTROPENIC SEPSIS 22 0.0031
389 GROWTH RETARDATION 9 0.0031
390 LUNG NEOPLASM 13 0.0030
391 ATRIOVENTRICULAR BLOCK COMPLETE 20 0.0030
392 SARCOIDOSIS 14 0.0029
393 ENCEPHALOPATHY 72 0.0029
394 HEPATITIS 75 0.0029
395 RHINITIS ALLERGIC 13 0.0029
396 BRONCHOPNEUMONIA 10 0.0029
397 HEPATIC NECROSIS 11 0.0029
398 HYPERURICAEMIA 12 0.0029
399 PARKINSONISM 28 0.0029
400 LIPASE INCREASED 22 0.0029
401 BILE DUCT STONE 9 0.0028
402 ENTERITIS 18 0.0028
403 END STAGE RENAL DISEASE 51 0.0028
404 MYOSITIS 25 0.0028
405 METABOLIC ACIDOSIS 89 0.0028
406 ACUTE MYOCARDIAL INFARCTION 82 0.0028
407 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 9 0.0028
408 HERPES SIMPLEX 18 0.0028
409 BACTERIAL SEPSIS 9 0.0028
410 HYPERPHAGIA 11 0.0028
411 IMMUNOSUPPRESSION 24 0.0027
412 BLOOD CREATINE INCREASED 12 0.0027
413 CYTOMEGALOVIRUS INFECTION 45 0.0027
414 PERIPHERAL VENOUS DISEASE 11 0.0027
415 ILEUS PARALYTIC 12 0.0027
416 NEUROTOXICITY 47 0.0027
417 BLOOD CREATINE PHOSPHOKINASE INCREASED 77 0.0027
418 TOXICITY TO VARIOUS AGENTS 451 0.0027
419 RHABDOMYOLYSIS 111 0.0027
420 AUTOIMMUNE HAEMOLYTIC ANAEMIA 9 0.0026
421 FIBROSIS 8 0.0026
422 SOCIAL AVOIDANT BEHAVIOUR 15 0.0026
423 BLOOD CREATININE INCREASED 168 0.0026
424 HAEMOLYTIC ANAEMIA 23 0.0026
425 CARDIOPULMONARY FAILURE 10 0.0026
426 EPSTEIN-BARR VIRUS INFECTION 16 0.0026
427 LEFT VENTRICULAR DYSFUNCTION 17 0.0025
428 HYDRONEPHROSIS 19 0.0025
429 DRUG LEVEL BELOW THERAPEUTIC 14 0.0025
430 POLYDIPSIA 10 0.0025
431 PROTHROMBIN TIME PROLONGED 15 0.0025
432 ECONOMIC PROBLEM 38 0.0025
433 CANDIDIASIS 10 0.0025
434 MALABSORPTION 13 0.0025
435 DRUG-INDUCED LIVER INJURY 78 0.0025
436 LIVER TRANSPLANT 9 0.0025
437 PANCYTOPENIA 138 0.0025
438 PARADOXICAL DRUG REACTION 9 0.0024
439 VENTRICULAR FIBRILLATION 27 0.0024
440 SPINAL COMPRESSION FRACTURE 20 0.0024
441 NEURODERMATITIS 9 0.0024
442 HEPATIC STEATOSIS 45 0.0024
443 BEHAVIOUR DISORDER 13 0.0024
444 BLOOD ALKALINE PHOSPHATASE INCREASED 59 0.0024
445 BRONCHIECTASIS 16 0.0024
446 COVID-19 PNEUMONIA 28 0.0024
447 PATHOLOGICAL FRACTURE 12 0.0024
448 GAMMA-GLUTAMYLTRANSFERASE INCREASED 52 0.0023
449 OESOPHAGEAL ULCER 9 0.0023
450 LIVER FUNCTION TEST ABNORMAL 68 0.0023
451 ARTERIOSCLEROSIS 22 0.0023
452 ANGINA UNSTABLE 15 0.0023
453 SUBCUTANEOUS ABSCESS 11 0.0023
454 HAEMODIALYSIS 19 0.0023
455 CHOLESTASIS 43 0.0022
456 NASAL POLYPS 11 0.0022
457 ANAL ABSCESS 12 0.0022
458 ELECTROCARDIOGRAM QT PROLONGED 80 0.0022
459 CORONARY ARTERY STENOSIS 11 0.0022
460 PNEUMONIA BACTERIAL 20 0.0022
461 AMYLASE INCREASED 8 0.0022
462 SUICIDAL IDEATION 197 0.0021
463 LEUKOENCEPHALOPATHY 8 0.0021
464 SOMNAMBULISM 14 0.0021
465 BUNDLE BRANCH BLOCK LEFT 9 0.0021
466 SINUS TACHYCARDIA 30 0.0021
467 ANAEMIA 402 0.0021
468 ACUTE RESPIRATORY DISTRESS SYNDROME 37 0.0021
469 ANURIA 18 0.0021
470 SEROTONIN SYNDROME 39 0.0020
471 PANCREATITIS 107 0.0020
472 ERYSIPELAS 10 0.0020
473 NERVOUS SYSTEM DISORDER 62 0.0020
474 SCHIZOPHRENIA 24 0.0020
475 TOXIC ENCEPHALOPATHY 10 0.0020
476 ACIDOSIS 15 0.0020
477 ISCHAEMIA 9 0.0020
478 FEMORAL NECK FRACTURE 10 0.0019
479 MENINGITIS 13 0.0019
480 APPENDICITIS 18 0.0019
481 LUNG INFILTRATION 17 0.0019
482 COAGULOPATHY 32 0.0019
483 MAJOR DEPRESSION 14 0.0019
484 LYMPHOPENIA 27 0.0019
485 BLOOD PROLACTIN INCREASED 9 0.0019
486 BRAIN OEDEMA 24 0.0019
487 RALES 11 0.0019
488 LYMPHADENOPATHY 67 0.0019
489 CENTRAL NERVOUS SYSTEM LESION 26 0.0019
490 LEFT VENTRICULAR HYPERTROPHY 8 0.0019
491 ENTEROCOCCAL INFECTION 9 0.0019
492 MULTI-ORGAN FAILURE 32 0.0018
493 HYPOKALAEMIA 84 0.0018
494 TUBULOINTERSTITIAL NEPHRITIS 34 0.0018
495 HAEMOLYSIS 14 0.0018
496 ACUTE CORONARY SYNDROME 15 0.0018
497 RENAL PAIN 19 0.0018
498 HYPERGLYCAEMIA 65 0.0018
499 GASTROENTERITIS 26 0.0018
500 PULMONARY HYPERTENSION 37 0.0018
501 EOSINOPHILIA 31 0.0018
502 CHOLELITHIASIS 58 0.0018
503 MULTIPLE FRACTURES 29 0.0018
504 HAEMATURIA 60 0.0018
505 CORONARY ARTERY DISEASE 53 0.0017
506 TRANSPLANT REJECTION 14 0.0017
507 LIVER DISORDER 77 0.0017
508 HERPES VIRUS INFECTION 10 0.0017
509 LYMPHOEDEMA 12 0.0017
510 HEPATOCELLULAR INJURY 24 0.0017
511 TACHYPNOEA 23 0.0017
512 ATAXIA 20 0.0017
513 HEMIPLEGIA 14 0.0017
514 HYPERKALAEMIA 59 0.0017
515 LYMPHOMA 26 0.0017
516 BRONCHOPULMONARY ASPERGILLOSIS 13 0.0017
517 MYOCARDIAL ISCHAEMIA 19 0.0017
518 RENAL FAILURE 221 0.0017
519 FACE OEDEMA 28 0.0017
520 ELECTROLYTE IMBALANCE 19 0.0016
521 EYELID OEDEMA 19 0.0016
522 INTESTINAL ISCHAEMIA 9 0.0016
523 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 28 0.0016
524 ANOREXIA 21 0.0016
525 PANCREATITIS ACUTE 36 0.0016
526 SKIN TOXICITY 9 0.0016
527 TOXIC SKIN ERUPTION 16 0.0016
528 RASH GENERALISED 41 0.0016
529 CHRONIC KIDNEY DISEASE 119 0.0016
530 EUPHORIC MOOD 16 0.0016
531 RENAL FAILURE CHRONIC 12 0.0016
532 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 40 0.0016
533 HEMIPARESIS 26 0.0015
534 FACIAL PARALYSIS 13 0.0015
535 BLOOD LACTATE DEHYDROGENASE INCREASED 24 0.0015
536 ARTERIOSCLEROSIS CORONARY ARTERY 10 0.0015
537 POLYNEUROPATHY 18 0.0015
538 PYELONEPHRITIS 13 0.0015
539 METASTASES TO LYMPH NODES 10 0.0015
540 POLYURIA 12 0.0015
541 NEPHROTIC SYNDROME 10 0.0015
542 CARDIOTOXICITY 13 0.0015
543 MUSCLE INJURY 12 0.0014
544 SEPTIC SHOCK 63 0.0014
545 MULTIPLE ORGAN DYSFUNCTION SYNDROME 41 0.0014
546 PRESCRIBED OVERDOSE 28 0.0014
547 CHOLECYSTITIS 17 0.0014
548 ACUTE PULMONARY OEDEMA 8 0.0014
549 FOOT FRACTURE 27 0.0014
550 GASTRIC ULCER 27 0.0014
551 BONE DENSITY DECREASED 44 0.0014
552 DIABETES MELLITUS 107 0.0014
553 PRODUCT TASTE ABNORMAL 19 0.0014
554 PSEUDOMONAS INFECTION 12 0.0014
555 SQUAMOUS CELL CARCINOMA 13 0.0014
556 ASPERGILLUS INFECTION 9 0.0014
557 ERECTILE DYSFUNCTION 35 0.0014
558 PURPURA 12 0.0014
559 CEREBRAL DISORDER 10 0.0014
560 AFFECT LABILITY 13 0.0013
561 STEVENS-JOHNSON SYNDROME 30 0.0013
562 SINUS BRADYCARDIA 13 0.0013
563 FACIAL PAIN 12 0.0013
564 DYSGEUSIA 99 0.0013
565 SUDDEN DEATH 14 0.0013
566 HEPATIC ENZYME INCREASED 90 0.0013
567 THROMBOCYTOPENIA 147 0.0013
568 SHOCK 30 0.0013
569 DIFFUSE LARGE B-CELL LYMPHOMA 10 0.0013
570 FEBRILE NEUTROPENIA 86 0.0013
571 RASH PAPULAR 29 0.0013
572 BLOOD POTASSIUM INCREASED 21 0.0013
573 FORMICATION 9 0.0013
574 RESPIRATORY FAILURE 94 0.0013
575 BLOOD CHOLESTEROL INCREASED 60 0.0013
576 DERMATITIS ALLERGIC 16 0.0013
577 VENTRICULAR TACHYCARDIA 21 0.0013
578 DEPRESSION 287 0.0013
579 HYPONATRAEMIA 71 0.0013
580 HEPATIC FUNCTION ABNORMAL 47 0.0013
581 MYOCLONUS 15 0.0013
582 GRIP STRENGTH DECREASED 11 0.0012
583 RHINITIS 10 0.0012
584 ANXIETY 345 0.0012
585 HYPOTONIA 12 0.0012
586 BLOOD UREA INCREASED 20 0.0012
587 HYPERTHYROIDISM 17 0.0012
588 MATERNAL EXPOSURE BEFORE PREGNANCY 8 0.0012
589 HYPOMAGNESAEMIA 16 0.0011
590 ORTHOSTATIC HYPOTENSION 20 0.0011
591 COORDINATION ABNORMAL 16 0.0011
592 DERMATITIS 24 0.0011
593 PHARYNGITIS 14 0.0011
594 DIALYSIS 16 0.0011
595 CANDIDA INFECTION 19 0.0011
596 DELIRIUM 39 0.0011
597 ABNORMAL DREAMS 31 0.0011
598 DEVELOPMENTAL DELAY 10 0.0011
599 PYREXIA 383 0.0011
600 RESPIRATORY DISTRESS 30 0.0011
601 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 52 0.0011
602 NEUTROPENIA 147 0.0011
603 MENTAL DISORDER 47 0.0011
604 ERYTHEMA MULTIFORME 10 0.0011
605 DIARRHOEA HAEMORRHAGIC 10 0.0011
606 ANGIOEDEMA 47 0.0011
607 NEUROPATHY PERIPHERAL 101 0.0011
608 MITRAL VALVE INCOMPETENCE 12 0.0011
609 LEUKOPENIA 53 0.0011
610 MYALGIA 180 0.0011
611 HYPERCALCAEMIA 13 0.0011
612 GENERALISED OEDEMA 13 0.0010
613 PARALYSIS 15 0.0010
614 QUALITY OF LIFE DECREASED 14 0.0010
615 HEPATIC CANCER 25 0.0010
616 ACUTE RESPIRATORY FAILURE 20 0.0010
617 THROMBOTIC MICROANGIOPATHY 10 0.0010
618 AGRANULOCYTOSIS 19 0.0010
619 ARRHYTHMIA 48 0.0010
620 HIATUS HERNIA 13 0.0010
621 FRACTURE 19 0.0010
622 WRIST FRACTURE 12 0.0010
623 INTENTIONAL PRODUCT USE ISSUE 87 0.0010
624 PERITONITIS BACTERIAL 10 0.0010
625 HYPERTENSIVE CRISIS 11 0.0010
626 BLOOD THYROID STIMULATING HORMONE INCREASED 9 0.0010
627 RENAL INJURY 29 0.0010
628 HICCUPS 8 0.0010
629 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 10 0.0010
630 HYPERAESTHESIA 8 0.0010
631 MENTAL STATUS CHANGES 27 0.0010
632 GENERALISED TONIC-CLONIC SEIZURE 16 0.0010
633 MUCOSAL INFLAMMATION 25 0.0010
634 TYPE 2 DIABETES MELLITUS 32 0.0009
635 SCRATCH 10 0.0009
636 NEURALGIA 23 0.0009
637 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 9 0.0009
638 LEUKOCYTOSIS 17 0.0009
639 HYPOTHYROIDISM 30 0.0009
640 SEPSIS 104 0.0009
641 CHROMATURIA 21 0.0009
642 GASTROINTESTINAL DISORDER 83 0.0009
643 COGNITIVE DISORDER 43 0.0009
644 CARDIAC ARREST 76 0.0009
645 DYSPHAGIA 87 0.0009
646 BACTERIAL INFECTION 17 0.0009
647 PHOTOSENSITIVITY REACTION 15 0.0009
648 DIABETES MELLITUS INADEQUATE CONTROL 16 0.0009
649 SPINAL FRACTURE 18 0.0009
650 MUSCLE SPASTICITY 11 0.0009
651 MALNUTRITION 10 0.0009
652 CEREBRAL HAEMORRHAGE 32 0.0009
653 GASTROINTESTINAL INFECTION 8 0.0009
654 EMPHYSEMA 9 0.0009
655 EMOTIONAL DISTRESS 108 0.0009
656 DEPRESSED MOOD 47 0.0009
657 TASTE DISORDER 18 0.0009
658 BONE MARROW FAILURE 18 0.0009
659 RIB FRACTURE 18 0.0009
660 VOMITING 410 0.0009
661 SKELETAL INJURY 9 0.0009
662 NEOPLASM 10 0.0009
663 IRON DEFICIENCY ANAEMIA 8 0.0009
664 GRAND MAL CONVULSION 8 0.0009
665 DISORIENTATION 34 0.0009
666 DISSEMINATED INTRAVASCULAR COAGULATION 12 0.0009
667 DYSARTHRIA 32 0.0008
668 DEHYDRATION 113 0.0008
669 GENERAL PHYSICAL HEALTH DETERIORATION 98 0.0008
670 DEVICE RELATED INFECTION 13 0.0008
671 ABDOMINAL PAIN 195 0.0008
672 GASTRITIS 22 0.0008
673 HYPERTENSION 176 0.0008
674 OEDEMA 45 0.0008
675 FLUID OVERLOAD 12 0.0008
676 C-REACTIVE PROTEIN INCREASED 30 0.0008
677 OESOPHAGITIS 9 0.0008
678 HYPOXIA 29 0.0008
679 DISEASE RECURRENCE 39 0.0008
680 BRADYCARDIA 43 0.0008
681 PULMONARY EMBOLISM 77 0.0008
682 NERVE INJURY 9 0.0008
683 HAEMATOCRIT DECREASED 16 0.0008
684 MOUTH ULCERATION 17 0.0008
685 CONVULSION 46 0.0008
686 SKIN LESION 22 0.0008
687 HYPOTHERMIA 8 0.0008
688 DIARRHOEA 510 0.0008
689 OEDEMA PERIPHERAL 96 0.0008
690 VERTIGO 48 0.0008
691 MYOCARDIAL INFARCTION 137 0.0008
692 DEPRESSED LEVEL OF CONSCIOUSNESS 31 0.0008
693 PSYCHOMOTOR HYPERACTIVITY 13 0.0008
694 ADVERSE EVENT 72 0.0008
695 CONFUSIONAL STATE 126 0.0008
696 SKIN DISORDER 26 0.0008
697 EAR DISCOMFORT 8 0.0008
698 DRUG INTOLERANCE 75 0.0008
699 NO ADVERSE EVENT 140 0.0008
700 BEDRIDDEN 10 0.0008
701 BACTERAEMIA 9 0.0008
702 DRUG ABUSE 63 0.0008
703 HALLUCINATION, AUDITORY 12 0.0008
704 OBESITY 12 0.0008
705 NIGHTMARE 26 0.0008
706 SLEEP DISORDER 53 0.0008
707 COVID-19 131 0.0007
708 MALIGNANT MELANOMA 10 0.0007
709 BLOOD SODIUM DECREASED 14 0.0007
710 DECREASED ACTIVITY 8 0.0007
711 PRODUCT USE IN UNAPPROVED INDICATION 183 0.0007
712 IMMUNODEFICIENCY 11 0.0007
713 COMA 35 0.0007
714 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 38 0.0007
715 TOXIC EPIDERMAL NECROLYSIS 11 0.0007
716 DRUG DISPENSING ERROR 11 0.0007
717 EPILEPSY 22 0.0007
718 MUSCLE ATROPHY 9 0.0007
719 SYNCOPE 71 0.0007
720 TACHYCARDIA 63 0.0007
721 GASTROOESOPHAGEAL REFLUX DISEASE 57 0.0007
722 CONTRAINDICATED PRODUCT ADMINISTERED 21 0.0007
723 CARDIO-RESPIRATORY ARREST 29 0.0007
724 METASTASES TO LUNG 8 0.0007
725 WEIGHT INCREASED 154 0.0007
726 RENAL DISORDER 32 0.0007
727 HAEMOGLOBIN DECREASED 70 0.0007
728 SARS-COV-2 TEST POSITIVE 9 0.0007
729 PNEUMONIA ASPIRATION 17 0.0007
730 HERPES ZOSTER 39 0.0007
731 WEIGHT DECREASED 187 0.0007
732 OSTEOMYELITIS 12 0.0007
733 CEREBRAL INFARCTION 16 0.0007
734 DYSURIA 24 0.0007
735 NAUSEA 516 0.0007
736 CIRCULATORY COLLAPSE 11 0.0006
737 OFF LABEL USE 564 0.0006
738 HYPOGLYCAEMIA 31 0.0006
739 SKIN REACTION 9 0.0006
740 BODY TEMPERATURE INCREASED 13 0.0006
741 STAPHYLOCOCCAL INFECTION 21 0.0006
742 CARDIOGENIC SHOCK 9 0.0006
743 ABSCESS 10 0.0006
744 RASH 273 0.0006
745 LETHARGY 36 0.0006
746 HEAD DISCOMFORT 11 0.0006
747 PULMONARY ARTERIAL HYPERTENSION 9 0.0006
748 UNRESPONSIVE TO STIMULI 16 0.0006
749 MENTAL IMPAIRMENT 15 0.0006
750 PNEUMONIA 200 0.0006
751 RESPIRATORY TRACT INFECTION 16 0.0006
752 IMMUNE SYSTEM DISORDER 8 0.0006
753 BONE DISORDER 11 0.0006
754 ALTERED STATE OF CONSCIOUSNESS 13 0.0006
755 THROMBOSIS 48 0.0006
756 ANGINA PECTORIS 17 0.0006
757 NIGHT SWEATS 19 0.0006
758 SKIN DISCOLOURATION 27 0.0006
759 TOOTH LOSS 12 0.0006
760 THERAPY NON-RESPONDER 26 0.0006
761 DEAFNESS 15 0.0006
762 MUSCULAR WEAKNESS 65 0.0006
763 ASTHENIA 214 0.0006
764 ULCER 9 0.0006
765 ABDOMINAL DISTENSION 59 0.0006
766 RASH ERYTHEMATOUS 27 0.0006
767 DRUG ERUPTION 10 0.0006
768 SUICIDE ATTEMPT 34 0.0006
769 HYPOTENSION 112 0.0006
770 SEIZURE 64 0.0006
771 RASH PRURITIC 30 0.0006
772 ACCIDENTAL OVERDOSE 20 0.0005
773 CONDITION AGGRAVATED 165 0.0005
774 OSTEOARTHRITIS 23 0.0005
775 CONJUNCTIVITIS 10 0.0005
776 DECREASED APPETITE 125 0.0005
777 SWELLING FACE 35 0.0005
778 HAEMORRHAGE 56 0.0005
779 PRODUCT PREPARATION ERROR 11 0.0005
780 LUNG NEOPLASM MALIGNANT 22 0.0005
781 PERITONITIS 11 0.0005
782 APHASIA 16 0.0005
783 PERICARDIAL EFFUSION 12 0.0005
784 GYNAECOMASTIA 16 0.0005
785 ANKLE FRACTURE 8 0.0005
786 MOOD ALTERED 14 0.0005
787 AMENORRHOEA 9 0.0005
788 HAEMORRHOIDS 10 0.0005
789 INSOMNIA 136 0.0005
790 ABNORMAL BEHAVIOUR 20 0.0005
791 THIRST 9 0.0005
792 COLITIS 19 0.0005
793 MOVEMENT DISORDER 16 0.0005
794 INFECTION 72 0.0005
795 CHEST PAIN 91 0.0005
796 EYE DISORDER 16 0.0005
797 GASTROINTESTINAL HAEMORRHAGE 40 0.0005
798 DEEP VEIN THROMBOSIS 31 0.0005
799 CARDIOVASCULAR DISORDER 12 0.0005
800 FEELING JITTERY 9 0.0005
801 SOMNOLENCE 94 0.0005
802 PANIC ATTACK 17 0.0005
803 LIVER FUNCTION TEST INCREASED 10 0.0005
804 IRRITABILITY 28 0.0005
805 DISTURBANCE IN ATTENTION 25 0.0005
806 CARDIAC FAILURE 37 0.0005
807 FATIGUE 356 0.0005
808 METASTASES TO LIVER 8 0.0005
809 MELAENA 10 0.0005
810 BLOOD PRESSURE DECREASED 30 0.0005
811 HEADACHE 283 0.0005
812 HYPERHIDROSIS 58 0.0004
813 OVERDOSE 97 0.0004
814 AMNESIA 29 0.0004
815 PALPITATIONS 52 0.0004
816 WHITE BLOOD CELL COUNT INCREASED 17 0.0004
817 SPEECH DISORDER 23 0.0004
818 CELLULITIS 22 0.0004
819 MUSCULOSKELETAL STIFFNESS 38 0.0004
820 MALAISE 190 0.0004
821 THERAPEUTIC RESPONSE DECREASED 26 0.0004
822 PLEURAL EFFUSION 26 0.0004
823 OXYGEN SATURATION DECREASED 24 0.0004
824 DYSPEPSIA 42 0.0004
825 DISCOMFORT 26 0.0004
826 PARAESTHESIA 67 0.0004
827 AGITATION 31 0.0004
828 BLOOD URINE PRESENT 8 0.0004
829 INTERNATIONAL NORMALISED RATIO INCREASED 12 0.0004
830 INCREASED APPETITE 8 0.0004
831 NEUTROPHIL COUNT DECREASED 17 0.0004
832 PRURITUS GENERALISED 9 0.0004
833 CLOSTRIDIUM DIFFICILE INFECTION 9 0.0004
834 DEATH 354 0.0004
835 COMPLETED SUICIDE 34 0.0004
836 AGGRESSION 20 0.0004
837 GAIT DISTURBANCE 76 0.0004
838 HAEMATEMESIS 10 0.0004
839 FEEDING DISORDER 8 0.0004
840 BONE PAIN 23 0.0004
841 SKIN EXFOLIATION 33 0.0004
842 LIP SWELLING 13 0.0004
843 ASTHMA 44 0.0004
844 PRODUCT USE ISSUE 73 0.0004
845 FEMUR FRACTURE 12 0.0004
846 HAEMATOMA 10 0.0004
847 RED BLOOD CELL COUNT DECREASED 11 0.0004
848 HYPERSENSITIVITY 71 0.0004
849 WHITE BLOOD CELL COUNT DECREASED 41 0.0004
850 EATING DISORDER 8 0.0004
851 DIABETIC KETOACIDOSIS 9 0.0004
852 FLATULENCE 21 0.0004
853 BLINDNESS 15 0.0004
854 PALLOR 10 0.0004
855 BACK PAIN 85 0.0004
856 RESPIRATORY ARREST 10 0.0004
857 MOBILITY DECREASED 26 0.0004
858 PRURITUS 139 0.0004
859 POLLAKIURIA 15 0.0004
860 URINARY RETENTION 12 0.0004
861 DIZZINESS 178 0.0004
862 THERAPEUTIC RESPONSE UNEXPECTED 16 0.0004
863 BLISTER 20 0.0004
864 LIMB DISCOMFORT 11 0.0004
865 WHEEZING 21 0.0004
866 HEART RATE IRREGULAR 8 0.0004
867 HYPOPHAGIA 9 0.0004
868 DYSPNOEA 199 0.0004
869 LOSS OF CONSCIOUSNESS 45 0.0004
870 COUGH 98 0.0003
871 RECTAL HAEMORRHAGE 15 0.0003
872 PLATELET COUNT DECREASED 37 0.0003
873 DYSPNOEA EXERTIONAL 13 0.0003
874 DRY MOUTH 28 0.0003
875 SEDATION 9 0.0003
876 RASH MACULAR 12 0.0003
877 CHILLS 40 0.0003
878 LABORATORY TEST ABNORMAL 10 0.0003
879 FEAR 9 0.0003
880 NEOPLASM MALIGNANT 22 0.0003
881 GAIT INABILITY 11 0.0003
882 URINARY TRACT INFECTION 56 0.0003
883 INTENTIONAL OVERDOSE 21 0.0003
884 ANGER 11 0.0003
885 HAEMOPTYSIS 9 0.0003
886 ABDOMINAL PAIN UPPER 66 0.0003
887 GASTRIC DISORDER 11 0.0003
888 HOSPITALISATION 49 0.0003
889 OCULAR HYPERAEMIA 15 0.0003
890 PAIN 194 0.0003
891 PULMONARY OEDEMA 14 0.0003
892 FEELING HOT 19 0.0003
893 DYSSTASIA 9 0.0003
894 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 9 0.0003
895 DISEASE PROGRESSION 36 0.0003
896 VIRAL INFECTION 10 0.0003
897 CARDIAC FAILURE CONGESTIVE 24 0.0003
898 MEMORY IMPAIRMENT 41 0.0003
899 STOMATITIS 18 0.0003
900 DRUG WITHDRAWAL SYNDROME 26 0.0003
901 TREMOR 49 0.0003
902 HALLUCINATION 22 0.0003
903 BLOOD GLUCOSE INCREASED 55 0.0003
904 ERYTHEMA 60 0.0003
905 DYSPHONIA 17 0.0003
906 INJECTION SITE REACTION 20 0.0003
907 DRUG INEFFECTIVE 383 0.0003
908 MEDICATION ERROR 16 0.0003
909 ARTHRALGIA 118 0.0003
910 PAIN IN EXTREMITY 82 0.0003
911 INCORRECT DOSE ADMINISTERED 63 0.0003
912 WRONG TECHNIQUE IN DRUG USAGE PROCESS 10 0.0003
913 PROSTATE CANCER 22 0.0003
914 RESTLESSNESS 10 0.0003
915 PSORIATIC ARTHROPATHY 11 0.0003
916 DYSKINESIA 11 0.0003
917 INFLUENZA LIKE ILLNESS 22 0.0003
918 SINUSITIS 27 0.0003
919 DRUG EFFECT DECREASED 14 0.0003
920 CEREBROVASCULAR ACCIDENT 44 0.0003
921 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 14 0.0003
922 BALANCE DISORDER 22 0.0003
923 PRODUCTIVE COUGH 12 0.0003
924 INTENTIONAL PRODUCT MISUSE 22 0.0003
925 NECK PAIN 14 0.0003
926 MYELOSUPPRESSION 9 0.0002
927 HIP FRACTURE 8 0.0002
928 ADVERSE DRUG REACTION 22 0.0002
929 PRODUCT SUBSTITUTION ISSUE 14 0.0002
930 FUNGAL INFECTION 8 0.0002
931 MUSCLE SPASMS 44 0.0002
932 ROAD TRAFFIC ACCIDENT 10 0.0002
933 UPPER RESPIRATORY TRACT INFECTION 11 0.0002
934 ARTHROPATHY 13 0.0002
935 VISION BLURRED 32 0.0002
936 URTICARIA 39 0.0002
937 MIGRAINE 22 0.0002
938 BRONCHITIS 17 0.0002
939 FEELING ABNORMAL 55 0.0002
940 ARTHRITIS 18 0.0002
941 INTERSTITIAL LUNG DISEASE 11 0.0002
942 HYPOAESTHESIA 34 0.0002
943 OROPHARYNGEAL PAIN 21 0.0002
944 CRYING 8 0.0002
945 LOWER RESPIRATORY TRACT INFECTION 10 0.0002
946 SKIN IRRITATION 10 0.0002
947 INJECTION SITE MASS 8 0.0002
948 ABDOMINAL DISCOMFORT 36 0.0002
949 EPISTAXIS 16 0.0002
950 MUSCULOSKELETAL PAIN 11 0.0002
951 SKIN BURNING SENSATION 15 0.0002
952 EYE IRRITATION 12 0.0002
953 NASAL CONGESTION 12 0.0002
954 BLOOD PRESSURE INCREASED 31 0.0002
955 ALOPECIA 39 0.0002
956 ACNE 15 0.0002
957 INFLUENZA 22 0.0002
958 CONSTIPATION 43 0.0002
959 ATRIAL FIBRILLATION 19 0.0002
960 NERVOUSNESS 10 0.0002
961 FALL 63 0.0002
962 CHEST DISCOMFORT 19 0.0002
963 MALIGNANT NEOPLASM PROGRESSION 19 0.0002
964 BURNING SENSATION 13 0.0002
965 ILLNESS 19 0.0002
966 PERIPHERAL SWELLING 28 0.0002
967 CARDIAC DISORDER 17 0.0002
968 HAEMATOCHEZIA 10 0.0002
969 EYE PAIN 10 0.0002
970 CONTUSION 17 0.0002
971 DRY SKIN 23 0.0002
972 VISUAL IMPAIRMENT 21 0.0002
973 UNDERDOSE 12 0.0002
974 INFLAMMATION 8 0.0002
975 PRODUCT DOSE OMISSION 10 0.0002
976 DRUG DEPENDENCE 24 0.0001
977 ILL-DEFINED DISORDER 9 0.0001
978 DEPENDENCE 8 0.0001
979 INJURY 10 0.0001
980 PSORIASIS 17 0.0001
981 SWELLING 11 0.0001
982 HEART RATE INCREASED 11 0.0001
983 NASOPHARYNGITIS 18 0.0001
984 DRUG DOSE OMISSION 15 0.0001
985 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 16 0.0001
986 PRODUCT DOSE OMISSION ISSUE 23 0.0001
987 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 14 0.0001
988 JOINT SWELLING 8 0.0001
989 PRODUCT QUALITY ISSUE 9 0.0001